SuperworthTreace Medical Concepts profit margin TMCI
Gross, operating and net profit as a share of revenue over the last twelve months, from 2020.
- Net margin, 12 months
- −29.0%
- Operating margin, 12 months
- −26.2%
- Net margin on a year earlier
- −6.0 pts
- Peer median
- 6.5%
Over the twelve months to Jun 30, 2026, Treace Medical Concepts kept −29.0% of its revenue as net profit, with an operating margin of −26.2% and a gross margin of 79.5%.
Five years earlier its net margin was −9.8%.
The median for 10 medical instruments and supplies stocks of a similar size is 6.5%.
Profit margin over time
Fiscal year by fiscal year
| Fiscal year | Net margin | Operating margin | Gross margin |
|---|---|---|---|
| FY2025 | −27.7% | −25.5% | 79.8% |
| FY2024 | −26.6% | −26.6% | 80.4% |
| FY2023 | −26.5% | −27.5% | 81.2% |
| FY2022 | −30.2% | −24.6% | 82.0% |
| FY2021 | −21.8% | −17.5% | 81.1% |
| FY2020 | −6.4% | 1.5% | 78.3% |
Quarter by quarter
| Quarter | Ended | Net margin, 12 months | Change on a year | Operating margin |
|---|---|---|---|---|
| Q2 FY26 | −29.0% | −6.0 pts | −26.2% | |
| Q1 FY26 | −29.4% | −4.3 pts | −26.9% | |
| Q4 FY25 | −27.7% | −1.1 pts | −25.5% | |
| Q3 FY25 | −22.9% | +7.4 pts | −22.1% | |
| Q2 FY25 | −23.0% | +9.1 pts | −22.4% | |
| Q1 FY25 | −25.1% | +2.8 pts | −24.8% | |
| Q4 FY24 | −26.6% | −0.2 pts | −26.6% | |
| Q3 FY24 | −30.3% | −3.0 pts | −30.7% | |
| Q2 FY24 | −32.1% | −6.8 pts | −32.7% | |
| Q1 FY24 | −27.9% | +2.5 pts | −28.9% | |
| Q4 FY23 | −26.5% | +3.7 pts | −27.5% | |
| Q3 FY23 | −27.3% | +8.6 pts | −27.6% |
Against its peers
Companies in Medical - Instruments & Supplies nearest Treace Medical Concepts' size, closest first, today.
| Company | Profit margin |
|---|---|
| TMCITreace Medical Concepts | −29.0% |
| INFUInfuSystem | 6.0% |
| UTMDUtah Medical Products | 29.0% |
| EMBCEmbecta | 8.6% |
| PDEXPro DEX | 17.6% |
| TCMDTactile Systems Technology | 7.1% |
| MDXGMimedx | 1.8% |
| MOVMovado | 6.0% |
| KEQUKewaunee Scientific | 3.0% |
| IRMDIradimed | 26.7% |
| STAAStaar Surgical | 1.1% |
| Peer median | 6.5% |
Where Treace Medical Concepts ranks
What the profit margin tells you
Profit as a share of revenue at three levels: gross (after making the product), operating (after running the business) and net (after everything, including tax and interest).
Compare within an industry. 10% is superb for a retailer and poor for a software company.
More on Treace Medical Concepts
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.